Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

Completed · Phase 2 · Has a placebo group

Conditions studied: Heart Failure, Congestive, Heart Decompensation, Left Ventricular Failure, Myocardiopathies, Systolic or Diastolic Left Ventricular Dysfunction

In brief

The study will evaluate the safety and efficacy of intravenous infusion of carperitide using pressure measurements inside the heart and great vessels and measuring carperitide concentration in the blood.

Key facts

Study ID

NCT00259038

Run by

Daiichi Sankyo

People needed

162

Starts

2004-01-01

Expected to finish

2006-02-01

Last updated by the study team

2016-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is hospitalized with congestive heart failure (CHF)
• Has a Swan-Ganz catheter inserted for CHF management and has pulmonary capillary wedge pressure 18 mmHg or higher

You may not qualify if…

• Has had a heart transplant
• Requires mechanical ventilation or mechanical circulatory support

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Los Angeles, California, United States
• Study site — Orange, California, United States
• Study site — San Diego, California, United States
• Study site — Bay Pines, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Springfield, Illinois, United States
• Study site — Covington, Louisiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Baltimore, Maryland, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — St Louis, Missouri, United States
• Study site — Albany, New York, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Cleveland, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Charleston, South Carolina, United States
• Study site — Columbia, South Carolina, United States
• Study site — Amarillo, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.